Compare Commvault Systems Inc (CVLT) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Commvault Systems Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Commvault Systems Inc trades at $157.25 (market cap $6.25B), while State Street SPDR S&P Biotech ETF trades at $153.75 (market cap $10.11B). The key difference: State Street SPDR S&P Biotech ETF is the larger of the two by market cap, and Commvault Systems Inc is more actively traded (632,727 versus 12,903,266). Which is the better fit depends on your goals — on Pluang, investors hold Commvault Systems Inc for 17 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| CVLT | XBI | |
|---|---|---|
Market Cap | $6.25B | $10.11B |
Volume | 632,727 | 12,903,266 |
Sector | Technology | Broad Market / Factor |
52-Week High | $176.52 | $169.55 |
52-Week Low | $75.18 | $104.99 |
Typical Hold Time | 17 Days | 38 Days |
Enterprise Value | $6.24B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVLT trades at $157.25, up 4.64% today, with a bullish technical signal and strong institutional interest. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Recent news highlights include achieving AWS Data Competency and expanding FedRAMP High authorization, reinforcing its cyber resilience leadership.
The outlook is positive, supported by analyst consensus and recent strategic wins, though high valuation multiples and a projected decline in net profit margin for 2026 present risks. Upside potential exists if earnings momentum continues, but investors should weigh premium valuations against growth sustainability.
XBI trades at $153.75, up 2.34% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts like the Merck-Moderna cancer vaccine breakthrough.
Outlook remains mixed with 100% analyst hold rating contrasting with bullish news catalysts. Key risks include high volatility, sector-specific regulatory pressures, and expense ratios higher than broader healthcare ETFs. The current technical setup near resistance requires monitoring for breakout confirmation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Commvault Systems Inc
Commvault provides enterprise-grade data protection and information management software. Its platform helps businesses manage, back up, and recover data across on-premises, cloud, and hybrid environments.
Read more on CVLT →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
